The invention relates to acetyl-CoA-carboxylase (ACC) inhibitors and to pharmaceutical compositions containing such compounds, for use in treating mycobacterial diseases. The invention further relates to a kit of parts comprising a pharmaceutical composition containing such compounds and at least one additional pharmaceutically active compound, selected from antbiotics, antifungals or anti-HIV compounds.